Back to search

Article

Potential therapy for progressive vision loss due to <i>PCDH15</i> -associated Usher Syndrome developed in an orthologous Usher mouse

2021-06-08

Abstract excerpt

Usher syndrome type I (USH1) is characterized by congenital deafness, vestibular areflexia, and progressive retinal degeneration with age. The protein-truncating p.Arg245* founder variant of PCDH15 has an ~2% carrier frequency among Ashkenazi Jews, accounting for nearly 60% of their USH1 cases. Here, longitudinal ocular phenotyping in thirteen USH1F individuals harboring the p.Arg245* variant revealed progressive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af5178b3-871d-5f74-b26a-1312fe073324
DOI
10.1101/2021.06.08.447565
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Potential therapy for progressive vision loss due to <i>PCDH15</i> -associated Usher Syndrome developed in an orthologous Usher mouseDOI 10.1101/2021.06.08.447565
Select a neighboring publication to make it the new centre.